United Kingdom of Great Britain and Northern Ireland
6 Vaccines Approved for Use in United Kingdom of Great Britain and Northern Ireland
Protein Subunit
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Approval Source: nytimes.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: bbc.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Approval Source: astrazeneca.com
Inactivated
12 in Clinical Trials in United Kingdom of Great Britain and Northern Ireland
Protein Subunit
Sanofi/GSK
Recombinant Protein
6 trials in 7 countries
Protein Subunit
Novavax
Nuvaxovid
Approved in 37 countries
16 trials in 12 countries
VLP
Medicago
Covifenz
Approved in 1 country
6 trials in 6 countries
RNA
Moderna
mRNA-1273.529
4 trials in 1 country
RNA
Moderna
Spikevax
Approved in 86 countries
67 trials in 23 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
AZD2816
2 trials in 2 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Inactivated
Valneva
VLA2001
Approved in 3 countries
6 trials in 3 countries
Live-Attenuated
Codagenix Inc
COVI-VAC
3 trials in 1 country
RNA
Gritstone Bio, Inc.
GRT-R910
2 Vaccines with Trials in United Kingdom of Great Britain and Northern Ireland are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries
RNA
Imperial